Organovo Holdings Inc.

11/13/2024 | Press release | Distributed by Public on 11/13/2024 07:44

Organovo to Present Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting Sponsored by the American Association for the Study of Liver Diseases

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.